Nubain, an injectable opioid, was effective for managing chronic pain in a recent study — without euphoria, sedation, tolerance or psychological side effects. Injecting Nubain daily, participants’ with previous level 8 to 10 pain had their pain reduced to a level 2 or 30. And the drug is already on the market.
It sounds too good to be true, but my heart still leapt when I read the Reuters article. I’ve got my fingers crossed.